Differences in β-cell function and insulin secretion in Black vs. White obese adolescents: do incretin hormones play a role?
Black children have a fourfold higher incidence of developing type 2 diabetes (T2D) compared with their White peers (1, 2) . The root cause of these disproportions are incompletely understood, and not completely accounted for by differences in obesity, diet, or levels of physical activity (3) (4) (5) . Previously, we (6, 7) and others (8) demonstrated that for the same degree of insulin sensitivity, Black youth have profound insulin hypersecretion compared with White youth in response to intravenous (iv) glucose challenge, partly explained by decreased insulin clearance (9) and an upregulated β-cell activity (10, 11) . However, investigations examining racial disparities in insulin secretion in response to oral glucose administration yielded inconsistent results. In obese adults, Blacks exhibit hyperinsulinemia and decreased insulin clearance compared with their White counterparts (12) . On the other hand, Black youth have reduced insulin concentrations compared with Latino youth (13) , whereas Black girls and women demonstrate higher acute insulin response and lower insulin sensitivity compared with Whites, independent of age (14) . To further explore the racial disparities in insulinemia in response to oral glucose, and examine the underlying mechanisms responsible for the observed contrast, we used an established mathematical model, elaborated in detail under calculations/methods, that considers the dynamic relationship between glucose concentration and insulin secretion from C-peptide during an oral glucose tolerance test (OGTT).
Gut derived incretin hormones, glucagon-like peptide 1 (GLP-1) and glucose-dependent insulinotropic polypeptide (GIP), play an important role in augmenting glucose-stimulated insulin secretion (15) making them potential candidates for the observed racial disparity in insulinemia/insulin secretion. However, racial differences in the incretin response to oral glucose are conflicting. In obese adults, Blacks had significantly higher fasting and postchallenge GLP-1 concentrations compared with Whites (12) , but Black youth were reported to have higher (12) or lower (16, 17) fasting GLP-1 and GLP-1 area under curve (AUC) compared with Whites. These investigations (12, 17) included youth with impaired glucose metabolism (IGM) and normal glucose tolerance (NGT) which may contribute to the aforementioned inconsistencies; as youth with impaired glucose tolerance (IGT) have impairments in the incretin effect compared with NGT youth (18) . In an effort to explain the upregulated β-cell function and insulin hypersecretion in otherwise healthy normoglycemic (6, 7, 11) Black youth, we investigated insulin secretion during a 2-h OGTT, using mathematical modeling, and incretin hormones in Black vs. White obese youth with NGT.
Research design and methods
Data were analyzed from 85 Black and 78 White obese adolescents, with NGT, who had an OGTT performed as part of their participation in the National Institutes of Health-funded studies of 'Childhood Metabolic Markers of Adult Morbidity in Blacks' (6, (18) (19) (20) . This was a subset of our previously published data examining β-cell function and incretin effect across the spectrum of dysglycemia from NGT to prediabetes to T2D (18) . The current subset was analyzed because they had NGT as our aim was to assess Black/White contrast under normal physiological conditions excluding dysglycemia. All studies were performed at the Pediatric Clinical and Translational Research Center (PCTRC) at Children's Hospital of Pittsburgh after parental consent and child assent were obtained. All participants were pubertal (Tanner II-V) and had exogenous obesity with no clinical evidence of endocrinopathy associated with obesity. Participants were advised to refrain from any physical activity, besides their daily routine and any dietary modification. None of the participants were involved in any exercise programs or weight modifying diets.
Fat free mass (FFM), fat mass (FM), and percent body fat (%BF) were evaluated with dual-energy xray absorptiometry (DEXA) as described previously (21) . Abdominal subcutaneous adipose tissue (SAT) and visceral adipose tissue (VAT) were assessed by magnetic resonance imaging (N = 125) (MRI) or computed tomography (N = 34) (CT) at L 4-5 intervertebral space (22, 23) . DEXA data are missing for three participants and abdominal adiposity data (three Black and one White) are missing in four due to technical difficulties and weight exceeding the limit of measurement. Clinical characteristics of the study participants are summarized in Table 1 .
Oral glucose tolerance test. Participants underwent a 2-h OGTT (1.75 g/kg, maximum 75 g) after a 10-12 h overnight fast (21, 24) . Blood samples were obtained at −15, 0, 15, 30, 60, 90, and 120 min for measurement of glucose, insulin, C-peptide, glucagon, total GLP-1, GIP, pancreatic polypeptide (PP), and free fatty acids (FFA). The latter was to assess for Black/White differences in FFA as a potential explanation for differences in insulin secretion.
Biochemical measurements. For the determination of insulin and C-peptide measurements, blood was collected at each sampling point and chilled in aprotinin/Ethylenediamine tetraacetic acid (EDTA) EDTA tubes as before (18) . Plasma glucose was determined, at the bed-side, by the glucose oxidase method using a glucose analyzer (Yellow Springs Instrument Co., Yellow Springs, OH, USA), and plasma insulin and C-peptide by commercially available radioimmunoassay (Millipore, St. Charles, MO, USA), as reported by us (24) . FFA was determined using enzymatic colorimetric methods with a Wako non-esterified fatty acid (NEFA)-HR (2) test kit (Wako, Osaka, Japan). Hemoglobin A1c (HbA1c) was measured by high performance liquid chromatography (A1c 2.2 Plus Glycohemoglobin Analyzer; Tosoh Medics, San Francisco, CA). Total GLP-1 was measured on a microplate reader (BioTek, Winooski, VT, USA) using a multi species total GLP-1 ELISA Kit (catalog no. EZGLP1T-36K; Millipore) and total GIP and PP were measured on the Luminex 200 IS (Luminex, Austin, TX, USA) using a two-plex human gut hormone Milliplex Kit (catalog no. HGT-68K-02; Millipore) (18) . Intra-assay and inter-assay coefficients of variation were 5.4 and 8.2% for GLP-1 and 5.1 and 9.1% for GIP.
Calculations. AUC was calculated with the use of the trapezoidal method. During the OGTT, early-phase responses were calculated as the AUC for the first 30 min and late-phase responses as the AUC for the last 90 min after the glucose challenge (18) . Mathematical modeling of plasma glucose and C-peptide concentrations during the OGTT were employed to assess β-cell function parameters, according to a previously developed model by Mari et al. (25, 26) . β-cell function parameters included β-cell glucose sensitivity (OGTT-βCGS) (in pmol/min/m 2 /mM), rate sensitivity (in pmol/m 2 /mM), and potentiation. OGTT-βCGS reflects the ability of the β-cell to respond to changes in prevailing plasma glucose concentration at any time point during the OGTT through a dose-response function relating insulin secretion and glucose concentration (26) . Rate sensitivity is the magnitude of the β-cell response to the rate of change in plasma glucose concentrations. The potentiation factor modulates the relationship between glucose concentration and insulin secretion by increasing the sensitivity of the β cells to subsequent plasma glucose concentration (26) . The potentiation factor comprises several mechanisms including release of endogenous incretin hormones, neuronal inputs, and changes in incremental plasma glucose concentrations after ingestion of the glucose load. Total insulin output relates to the AUC of insulin secretion during the 2-h OGTT (expressed in nmol/m 2 ). Basal and stimulated insulin clearance was calculated from the ratio of insulin secretion AUC/insulin AUC (27) . A model-based index of insulin sensitivity [oral glucose insulin sensitivity (OGIS)], validated against the hyperinsulinemic euglycemic clamp, was calculated using the plasma glucose and insulin concentrations during the 2-h OGTT (28) .
Statistical analysis. Subject characteristics, β-cell
function parameters and early and late phase incretin response were determined using a Student T-test for quantitative variables and chi-squared test for categorical variables between groups. Analysis of covariance (ancova) models were used to assess between group differences adjusting for Tanner stage. A repeated-measures ancova (within-subjects factor of time; between-subjects factor of race, i.e., Black vs. White; time × race interaction) was used to analyze glucose, hormone, and incretin response to oral glucose. Log transformations were used to normalize the distribution for insulin and GLP-1. All other variables were normally distributed. Data are presented as mean ± SEM. Statistical significance was set at p < 0.05 and the statistical analyses were performed using pasw statistics (version 20, SPSS Inc., Chicago, IL, USA).
Results

Participant characteristics
Black and White adolescents were similar in age, gender, body mass index (BMI), FFM, and %BF. Compared with White youth, a greater proportion of Blacks were Tanner stage IV-V, had lower VAT, lower VAT-to-SAT ratio, and higher HbA1c (Table 1) . OGIS was similar between Blacks and Whites before and after adjusting for differences in VAT and Tanner stage.
Glucose, C-peptide, glucagon, and modeled β-cell function parameters during the OGTT Fasting glucose and C-peptide were lower in Blacks compared with Whites (Fig. 1) . During the OGTT, glucose concentrations (Fig. 1A) and AUC (795.6 ± 10.6 vs. 846.4 ± 10.6, p = 0.001) were lower in Blacks compared with Whites (main effect of race, p = 0.001). Early insulin secretion showed a rapid and pronounced increase followed by a rapid decline in Black youth compared with Whites (Fig. 1C) (time × race interaction, p < 0.001) consistent with the reduced late-phase rise in C-peptide (Fig. 1B) (time × race interaction, p = 0.03), which remained significant after controlling for differences in glucose response during the OGTT and Tanner stage. Coherent with the insulin secretion, early potentiation factor and AUC in the first 30 min of the OGTT were higher in Blacks vs. Whites (p < 0.02 and p = 0.05, respectively) (Fig. 1D) , together with higher βCGS and rate sensitivity in Blacks ( Fig. 2A, B) . C-peptide AUC was lower in Blacks (328.1 ± 13.6 vs. 373.2 ± 14.1, p = 0.01), but insulin AUC was similar between Black and Whites (110 908.7 ± 8806.3 vs. 114 450.0 ± 8240.9, p = NS). Basal insulin secretion, total insulin output, and basal and stimulated insulin clearance rates were lower in Blacks compared with Whites (Fig. 2C, F) .
Incretin response, PP, glucagon, and FFA concentrations during the OGTT are depicted in Fig. 3 . Fasting incretin and FFA concentrations did not differ between the two groups. During the OGTT, GLP-1 AUC was similar between Blacks and Whites (1644.9 ± 117.4 vs. 1711.9 ± 118.2; p = 0.67) (Fig. 3A) . GIP and PP responses showed a significant time × race interaction with Blacks having a more pronounced early PP response and a greater sustainability of GIP concentrations compared with Whites (Fig. 3B,  C) . Glucagon and FFA concentrations were similar between Blacks and Whites (Fig. 3D, E) .
Determinants of glucose, C-peptide, and insulin clearance during the OGTT.
In an effort to examine the determinants of glycemia and β-cell function during the OGTT, multiple linear regression models were used (Table 2) . Race was a significant independent contributor to the variance in C-peptide AUC of the OGTT and insulin clearance but not OGTT glucose AUC. For the latter, 73% of the variance was explained by insulin sensitivity, βCGS, rate sensitivity, insulin clearance, and Tanner stage (independent variables: age, sex, Tanner stage, race, VAT, insulin sensitivity, GLP-1 AUC, βCGS, potentiation ratio, rate sensitivity, and insulin clearance). As βCGS, rate sensitivity, and insulin clearance were significantly different between Blacks and Whites, a second model was constructed removing these parameters which yielded insulin sensitivity, race, VAT and sex explaining 34% of the variance in glucose AUC. For Cpeptide AUC, 68% of the variance was explained by insulin sensitivity, rate sensitivity, race and sex, each independently and significantly contributing to the model. With respect to OGTT insulin clearance, insulin sensitivity, race, and VAT explained 46% of the variance.
Discussion
In our continued efforts to examine the mechanism(s) behind the upregulated β-cell function and the hyperinsulinemia in Black vs. White youth, the current investigation, using mathematical modeling of β-cell function during an OGTT revealed that: (i) Black youth have a heightened early insulin secretion compared with Whites coincident with (ii) a higher βCGS, rate sensitivity and early potentiation factor but (iii) no differences in mean incretin concentrations except for a race-dependent difference in the temporal pattern in GIP and PP, and (iv) lower insulin clearance.
During an iv glucose challenge and for the same degree of insulin sensitivity, Black youth have an exaggerated early insulin response compared with Whites (6-8). However, during an OGTT racial disparities in insulin secretion are inconsistent (12) (13) (14) . Compared with their White counterparts, Black obese adults exhibited hyperinsulinemia and decreased insulin clearance (12) . Conversely, Black youth had reduced insulin concentrations compared with Latino youth (13) , yet Black females demonstrated a higher acute insulin response and lower insulin sensitivity compared with Whites (14) . This study, employing mathematical modeling of β-cell function revealed consistent findings with iv glucose challenge in adults (29) (30) (31) and youth (21, (32) (33) (34) (35) (36) (37) . Black youth had approximately 15% higher early insulin secretion in harmony with the 12% higher βCGS and the 33% higher rate sensitivity, corresponding to a greater β-cell response to changes in glucose concentrations. However, unlike previous investigations (8, 10) where Blacks had lower insulin sensitivity compared with Whites, OGTT insulin sensitivity by OGIS, was similar between Black and White youth. We previously demonstrated that the racial disparity in insulin sensitivity is only detected in normal weight youth and not in obese youth (6, 38) akin to the present investigation. This is because the obesity-associated insulin resistance overshadows the race-associated insulin resistance of much lesser magnitude (7) . Furthermore, our past observations of lower insulin sensitivity in normal weight Black vs. White youth were made using the hyperinsulinemic-euglycemic clamp, which is a much more sensitive method of assessing insulin sensitivity (where both insulin and glucose concentrations are clamped) than an OGTT-derived index of insulin sensitivity (where glucose and insulin concentrations vary among participants). However, the OGTT-derived OGIS is in agreement with others employing the OGTTderived whole-body insulin sensitivity index (12) and the frequently-sampled iv glucose tolerance test using minmod (14) . Irrespective, the present data and past observations, suggests that while interpreting insulinemia during an OGTT, race should be taken into consideration.
The literature with respect to racial differences in GLP-1 and GIP are controversial showing increased or decreased concentrations in Blacks compared with Whites. In severely obese Black adults, fasting GLP-1 and GLP-1 AUC were significantly higher than in Whites (12, 39) . On the other hand, in overweight to obese adolescents, total GLP-1 AUC was significantly lower in Blacks compared with Whites (17) . Using a mixed macronutrient meal, Black children demonstrated lower early-and latephase GLP-1 response whereas GIP response did not differ compared with Whites (16). In our study, earlyand late-phase AUC for GLP-1, GIP, PP, and FFAs were similar. The inconsistencies in the literature may be due to differences in measuring active vs. total GLP-1 (40), differences in participant characteristics, and the different liquid meals used to assess incretin response. The observed lower GLP-1 in Black vs White youth by Higgins et al. may be the result of measuring active GLP-1 and having used a mixed macronutrient meal (16) in contrast to total GLP-1 and the oral glucose load in our study. Furthermore, several investigations included a mixed-sample of participants with normal glucose metabolism and IGM (12, 17, 39) . Differences in incretin concentrations and effect have been described, with IGM youth having higher GLP-1 AUC than NGT youth (17) , and IGT youth showing impaired incretin effect compared with NGT (18) . Therefore, heterogeneity of glucose metabolism may be contributing to the different study findings with respect to incretin hormones.
We also observed significant differences in the temporal patterns in PP and GIP between races. Blacks demonstrated a greater early augmentation in PP followed by a rapid and consistent decline at minute 30 compared with Whites. While GIP increased similarly for the first 30 min, Blacks sustained higher GIP concentrations over the remainder of the OGTT unlike their White peers. It remains to be determined if these subtle temporal differences in incretin concentrations translate to functional differences as the former only partially relates to the function of the incretin hormones. In this regard, we examined the potentiation factor, which comprises several mechanisms including release of endogenous incretin hormones, neuronal inputs, and changes in incremental plasma glucose concentrations after ingestion of the glucose load. Blacks demonstrated a higher early phase potentiation factor (Fig. 1D ) consistent with the higher early-phase insulin secretion compared with Whites (Fig. 1C) . It remains to be investigated if race-related differences in neuronal input are operational in modulating insulin secretion. Lastly and consistent with past observations (6, 9, 41), insulin clearance was significantly lower in Black vs. White youth, partially explaining the frequently reported hyperinsulinemia in Blacks. In this study, the determinants of insulin clearance were race, VAT, and insulin sensitivity explaining 46% of its variance. Thus, to avoid the confounding influence of insulin clearance, C-peptide may be a better measure of insulin secretion especially when comparing and contrasting race-related differences in insulinemia and β-cell function. Finally, there were no race-related differences in FFA concentrations during the OGTT to explain differences in insulin secretion or clearance.
The strengths of this investigation include (i) the large number of carefully characterized and uniformly NGT obese Black and White youth and (ii) the mathematical modeling. The fact that insulin sensitivity was similar between groups may be viewed as a strength in the current investigation although this may be biased by the significant differences in pubertal stage between the two groups.
In conclusion, during an OGTT Black obese youth with NGT demonstrate a pronounced early insulin secretion jointly with heightened β-cell glucose sensitivity, rate sensitivity, and early potentiation factor which do not appear to be driven by differences in incretin hormones. The mechanism(s) behind these racial disparities remain to be investigated further in an effort to probe the metabolic basis for the increased risk of T2D in obese Black youth compared with their White peers.
